RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
📌 Un estudio muestra que los sintomas #PostCovid19 pueden durar 52% a los 30 días y un 35 % a los 60 días. #LongCovid #Chequealo #COVID19 #CID https://t.co/djT3LvRiln
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @maureviv: IDSA has published a piece on #LongCovid
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
RT @ahandvanish: Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. T…
IDSA has published a piece on #LongCovid
Wow - new prevalence study looking specifically at symptomatic COVID patients finds 35% still symptomatic at 2 months. The current #LongCovid estimate including originally asymptomatic cases is 14% at 3 months, so this is a big finding & increased pr
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @ItsAngInLA: So estimates of 1/3 of COVID patients will get #LongCovid seem to be right on target…
RT @ItsAngInLA: So estimates of 1/3 of COVID patients will get #LongCovid seem to be right on target…
So estimates of 1/3 of COVID patients will get #LongCovid seem to be right on target…
Destacado de hoy: Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics | Clinical Infectious Diseases | Oxford Academic https://t.co/Umca4iqz7V, see more https://t.co/yP8lD23EJG
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
RT @IDSAInfo: New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days…
New in CID: In a population-based probability sample of 593 symptomatic COVID-19 cases, 52.5% had persistent symptoms 30 days post-onset, with 35.0% symptomatic 60 days post-onset. 📄:https://t.co/GtOuGx0Zjm #ClinInfectDis #IDSAJournals https://t.co/Q5MCk
Population-based estimates of post-acute sequelae of SARS-CoV-2 infection prevalence and characteristics https://t.co/YcJWpqgZn1 PASC is highly prevalent among cases reporting severe initial symptoms, and, to a lesser extent, cases reporting mild and mode
Long covid - 35% of people who had symptomatic #covid19 still had symptoms at 60 days post acute infection Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics https://t.co/nkRyhoBDEN
RT @TimLaheyMD: In a survey of 629 Michigan adults who recovered from COVID, HALF still had symptoms 1 month later A third had them at 2…
Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics https://t.co/YEsYUtN12t Emerging evidence suggests many people have persistent symptoms after acute COVID-19 illness. Our objective was to esti
In a survey of 629 Michigan adults who recovered from COVID, HALF still had symptoms 1 month later A third had them at 2 months https://t.co/z0pAXBtIu3 HT @SaskiaPopescu https://t.co/z19jDx4hl6
Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics | Clinical Infectious Diseases | Oxford Academic https://t.co/4DseXfCaxA
3,118/ Michigan, USA (adult smoking rate was 18.9% in 2019) Of 593 with confirmed SARS-CoV-2 infection who responded to a survey, 6.3%* were current smokers immediately prior to illness *weighted https://t.co/jqZ7ldaPAm
Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics | Clinical Infectious Diseases | Oxford Academic https://t.co/LoRPKBipqy
RT @chrishendel: Ugh #LongCovid "Although 30-day & 60-day #COVID19 were more prevalent among individuals w/severe illness in our study, t…
Ugh #LongCovid "Although 30-day & 60-day #COVID19 were more prevalent among individuals w/severe illness in our study, they were still highly prevalent among individuals w/self-reported mild to moderate illness." https://t.co/qOspcfL0ft Prevalent sy